BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 943556)

  • 1. Determination of adhesive properties of variant metastatic melanoma cells to BALB/3T3 cells and their virus-transformed derivatives by a monolayer attachment assay.
    Winkelhake JL; Nicolson GL
    J Natl Cancer Inst; 1976 Feb; 56(2):285-91. PubMed ID: 943556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tertiary amine local anesthetics on the blood-borne implantation and cell surface properties of metastatic mouse melanoma cells.
    Nicolson GL; Fidler IJ; Poste G
    J Natl Cancer Inst; 1986 Mar; 76(3):511-9. PubMed ID: 3456465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selection and characterization of an invasive variant of the B16 melanoma.
    Hart IR
    Am J Pathol; 1979 Dec; 97(3):587-600. PubMed ID: 507192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.
    Fidler IJ; Nicolson GL
    Isr J Med Sci; 1978 Jan; 14(1):38-50. PubMed ID: 632082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
    Fidler IJ; Nicolson GL
    J Natl Cancer Inst; 1976 Nov; 57(5):1199-202. PubMed ID: 1003551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesive properties of weakly and highly metastatic melanoma cell lines.
    Urushihara H; Ikawa Y; Tsuruo T
    Gan; 1984 Jun; 75(6):534-9. PubMed ID: 6088347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties.
    Nicolson GL; Dulski K; Basson C; Welch DR
    Invasion Metastasis; 1985; 5(3):144-58. PubMed ID: 3997411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells.
    Hart IR; Raz A; Fidler IJ
    J Natl Cancer Inst; 1980 Apr; 64(4):891-900. PubMed ID: 6929000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glycoconjugates in metastatic melanoma blood-borne arrest and cell surface properties.
    Irimura T; Nicolson GL
    J Supramol Struct Cell Biochem; 1981; 17(4):325-36. PubMed ID: 7328676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
    Humphries MJ; Yamada KM; Olden K
    J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence probes in metastatic B16 melanoma membranes.
    Schroeder F
    Biochim Biophys Acta; 1984 Oct; 776(2):299-312. PubMed ID: 6477911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures.
    Passaniti A; Hart GW
    J Biol Chem; 1988 Jun; 263(16):7591-603. PubMed ID: 3372501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of metastatic responsiveness to cell shape modulation in a newly characterized B16 melanoma adhesive cell variant.
    Nabi IR; Raz A
    Cancer Res; 1988 Mar; 48(5):1258-64. PubMed ID: 3342405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation.
    Lotan R; Raz A
    Cancer Res; 1983 May; 43(5):2088-93. PubMed ID: 6187442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma cell lines selected in vitro for increased homotypic adhesion properties have increased experimental metastatic potential.
    Updyke TV; Nicolson GL
    Clin Exp Metastasis; 1986; 4(4):273-84. PubMed ID: 3791726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.
    Nicolson GL; Inoue T; Van Pelt CS; Cavanaugh PG
    Cancer Res; 1990 Feb; 50(3):515-20. PubMed ID: 2297694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.